BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14691448)

  • 41. A novel transgenic mouse model of hyperfibrinogenemia.
    Gulledge AA; Rezaee F; Verheijen JH; Lord ST
    Thromb Haemost; 2001 Aug; 86(2):511-6. PubMed ID: 11521996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Branching out with BRCA1.
    Dennis C
    Nat Genet; 1999 May; 22(1):10. PubMed ID: 10319850
    [No Abstract]   [Full Text] [Related]  

  • 43. The role of human cervical cancer oncogene in cancer progression.
    Li XY; Wang X
    Int J Clin Exp Med; 2015; 8(6):8363-8. PubMed ID: 26309489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The Wnt1 oncogene: from mice mammary tumors to human tumors (continuation)].
    Larsen CJ
    Bull Cancer; 1999 Mar; 86(3):252. PubMed ID: 10847723
    [No Abstract]   [Full Text] [Related]  

  • 45. Oncogene mediated signal transduction in transgenic mouse models of human breast cancer.
    Siegel PM; Dankort DL; Muller WJ
    Adv Exp Med Biol; 2000; 480():185-94. PubMed ID: 10959426
    [No Abstract]   [Full Text] [Related]  

  • 46. Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.
    Marcotte R; Muller WJ
    J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):323-35. PubMed ID: 18651209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
    Blackburn AC; Jerry DJ
    Breast Cancer Res; 2002; 4(3):101-11. PubMed ID: 12052252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HCCR-1, a novel oncogene, encodes a mitochondrial outer membrane protein and suppresses the UVC-induced apoptosis.
    Cho GW; Shin SM; Kim HK; Ha SA; Kim S; Yoon JH; Hur SY; Kim TE; Kim JW
    BMC Cell Biol; 2007 Nov; 8():50. PubMed ID: 18045496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One medicine: an introduction.
    Gardner MB
    Breast Dis; 2007; 28():1-5. PubMed ID: 18057538
    [No Abstract]   [Full Text] [Related]  

  • 50. HGF induces oncoprotein HCCR-1 expression through the Wnt/β-catenin pathway in gastric cancer.
    Koh SA; Jung JY; Kim JR; Lee KH
    Am J Transl Res; 2022; 14(3):1507-1517. PubMed ID: 35422931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mouse models for sporadic cancer.
    Meuwissen R; Jonkers J; Berns A
    Exp Cell Res; 2001 Mar; 264(1):100-10. PubMed ID: 11237526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contributions of mouse biology to breast cancer research.
    Cardiff RD; Bern HA; Faulkin LJ; Daniel CW; Smith GH; Young LJ; Medina D; Gardner MB; Wellings SR; Shyamala G; Guzman RC; Rajkumar L; Yang J; Thordarson G; Nandi S; MacLeod CL; Oshima RG; Man AK; Sawai ET; Gregg JP; Cheung AT; Lau DH
    Comp Med; 2002 Feb; 52(1):12-31. PubMed ID: 11900409
    [No Abstract]   [Full Text] [Related]  

  • 53. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.
    Zhang Y; Xiong S; Liu B; Pant V; Celii F; Chau G; Elizondo-Fraire AC; Yang P; You MJ; El-Naggar AK; Navin NE; Lozano G
    Nat Commun; 2018 Sep; 9(1):3953. PubMed ID: 30262850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transgenic mouse models--a seminal breakthrough in oncogene research.
    Smith HW; Muller WJ
    Cold Spring Harb Protoc; 2013 Dec; 2013(12):1099-108. PubMed ID: 24298026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transdifferentiation-inducing HCCR-1 oncogene.
    Ha SA; Kim HK; Yoo J; Kim S; Shin SM; Lee YS; Hur SY; Kim YW; Kim TE; Chung YJ; Jeun SS; Kim DW; Park YG; Kim J; Shin SY; Lee YH; Kim JW
    BMC Cell Biol; 2010 Jun; 11():49. PubMed ID: 20591135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human cervical cancer oncogene-1 over expression in colon cancer and its clinical significance.
    Meng K; Yuan M; Xu S; Wang L; Li Z; Wang M; Ma R
    Int J Clin Exp Med; 2015; 8(1):939-43. PubMed ID: 25785079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of gene expression profiling for validating models of human breast cancer.
    Green JE; Desai KV; Ye Y; Kavanaugh C; Calvo A; Huh JI
    Toxicol Pathol; 2004; 32 Suppl 1():84-9. PubMed ID: 15209407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HCCR-1 is a Novel Prognostic Indicator for Gastric Cancer and Promotes Cell Proliferation.
    Zhu LF; Ma P; Hu YL; Feng Y; Li P; Wang H; Guo YB; Mao QS; Xue WJ
    J Cancer; 2019; 10(15):3533-3542. PubMed ID: 31293658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevention of mammary tumorigenesis in mice: a hope for the women at risk for breast cancer].
    Gilgenkrantz S
    Med Sci (Paris); 2007 Jan; 23(1):107-8. PubMed ID: 17212943
    [No Abstract]   [Full Text] [Related]  

  • 60. Mutant p53 and genomic instability in a transgenic mouse model of breast cancer.
    Murphy KL; Rosen JM
    Oncogene; 2000 Feb; 19(8):1045-51. PubMed ID: 10713688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.